We are live on ! Find out more
AE

Axon Enterprise Portfolio holdings

AUM $19.1M
1-Year Est. Return 8.75%
This Fund
S&P 500
This Quarter Est. Return
-17.65%
1 Year Est. Return
-8.75%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$144M
AUM Growth
-$30.9M
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
1
New
–
Increased
–
Reduced
–
Closed
–

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CLBT icon
1
Cellebrite
CLBT
$3.01B
$144M 100%
9,000,000
– –

Similar funds

LFA
LGT Financial Advisors Dallas, Texas $18.9M AUM 25.06% 1-Year Est. Return
BIMC
Benson Investment Management Company Roanoke, Virginia $18.8M AUM 23.67% 1-Year Est. Return
IACCGIA
IDG-Accel China Capital GP II Associates Hong Kong $19.5M AUM
PMAM
Penn Mutual Asset Management Conshohocken, Pennsylvania $19.5M AUM 3.07% 1-Year Est. Return
SRHG
Stone Ridge Holdings Group New York $18.6M AUM 9.31% 1-Year Est. Return
VAM
Vazirani Asset Management New York $20.3M AUM 79.33% 1-Year Est. Return
FS
Financially Speaking Greenwood Village, Colorado $20.6M AUM 16.79% 1-Year Est. Return
MPW
MGO Private Wealth Irvine, California $20.7M AUM 18.57% 1-Year Est. Return

Axon Enterprise's Q2 2025 Portfolio in Review

As of Q2 2025, Axon Enterprise held 1 position worth $144M, down 18% from $175M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2025: portfolio turnover was 0%. Axon Enterprise opened no new positions and made no exits, leaving the 1-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 100% of assets, unchanged from a quarter earlier.

  • Axon Enterprise's ten largest holdings make up 100% of its $144M portfolio in Q2 2025.
  • Axon Enterprise opened 0 new positions and closed 0 in Q2 2025.
  • Axon Enterprise's portfolio value fell 18% quarter-over-quarter to $144M.

Based on Axon Enterprise's 13F filing for Q2 2025, filed 14 Aug 2025.